iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.9617
-0.0483 (-4.78%)
Oct 8, 2026, 12:24 PM EDT - Market open

iBio, Inc. Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, iBio, Inc. stock has a consensus rating of "Strong Buy" and an average price target of $5.69. The average 1-year stock price forecast is 491.66% higher than the current stock price, while the lowest is $4.20 (+336.73%) and the highest is $7.00 (+627.88%).

Price Target: $5.69 (+491.66%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.20$5.69$6.00$7.00
Change+336.73%+491.66%+523.90%+627.88%

Analyst Ratings

The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy677788
Buy011111
Hold000000
Sell000000
Strong Sell000000
Total688899

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Maintains
$7
BuyMaintains$7+627.88%Oct 2, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$6
BuyInitiates$6+523.90%Aug 31, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$5
BuyMaintains$5+419.91%Aug 28, 2026
Chardan Capital
Chardan Capital
Buy
Reiterates
$5
BuyReiterates$5+419.91%Jul 2, 2026
Raymond James
Raymond James
Buy
Initiates
$5
BuyInitiates$5+419.91%Jun 8, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
25.00K
from 100.00K
Decreased by -75.00%
Revenue Next Year
20.00K
from 25.00K
Decreased by -20.00%
EPS This Year
-0.38
from -0.32
EPS Next Year
-0.61
from -0.38
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
1.88M-225.00K400.00K100.00K25.00K
Revenue Growth
-20.54%--77.78%-75.00%-75.00%
Operating Income
-29.70M-28.78M-16.63M-18.60M-30.14M-55.40M
Net Income
-50.30M-65.01M-24.91M-18.38M-33.04M-50.32M
EPS
-----0.32-0.38
Free Cash Flow
-----23.80M-64.40M
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High100,000
Avg25,000
Lown/a

Revenue Growth

Revenue Growth202720282029
High-
Avg
-75.0%
Low
-100.0%

EPS Forecast

EPS202720282029
High-0.22
Avg-0.38
Low-0.85

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-